Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Shares Outstanding (2018 - 2025)

Dna X (SONM) has disclosed Shares Outstanding for 8 consecutive years, with $1.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding rose 275.25% year-over-year to $1.0 million, compared with a TTM value of $1.0 million through Sep 2025, up 275.25%, and an annual FY2024 reading of $5.0 million, up 1926.36% over the prior year.
  • Shares Outstanding was $1.0 million for Q3 2025 at Dna X, up from $574353.0 in the prior quarter.
  • Across five years, Shares Outstanding topped out at $42.6 million in Q3 2023 and bottomed at $245952.0 in Q4 2023.
  • Average Shares Outstanding over 5 years is $14.1 million, with a median of $6.6 million recorded in 2021.
  • The sharpest move saw Shares Outstanding soared 339.39% in 2022, then plummeted 93.97% in 2023.
  • Year by year, Shares Outstanding stood at $18.8 million in 2021, then tumbled by 78.32% to $4.1 million in 2022, then tumbled by 93.97% to $245952.0 in 2023, then increased by 12.58% to $276881.0 in 2024, then skyrocketed by 266.82% to $1.0 million in 2025.
  • Business Quant data shows Shares Outstanding for SONM at $1.0 million in Q3 2025, $574353.0 in Q2 2025, and $6.3 million in Q1 2025.